Capricor Therapeutics is trading at $8.06, up 11.33%, with biotech-sector strength the clearest available context on November 3, 2026. - The XBI rose 2.13% during the regular session. - No specific company announcement explaining the gain was identified. - Capricor announced it will report third-quarter results and provide a corporate update on November 10; that scheduled event does not establish the cause of the November 3 move.